The U.S. Food and Drug Administration has cleared a new remote glucose monitoring system that can transmit data directly to the smartphones of up to five designated "followers."
The Dexcom G4 Platinum Continuous Glucose Monitoring System with Share uses a secure Bluetooth connection and a smartphone app to transmit glucose information directly to a corresponding app on the designated recipients' mobile devices.
By being able to receive this data wirelessly, the recipient—such as a healthcare provider or family member—can remotely monitor glucose levels and receive alert notifications.
Currently available at no charge for the iPhone and iPod touch, the monitoring system will soon be available for Android devices as well.
"The Dexcom Share receiver represents a significant step forward for our company and our mobile strategy, but more importantly, it will provide a huge improvement for people managing their diabetes and for those parents and caregivers who help them each and every day," said Kevin Sayer, president and CEO of Dexcom in a press release. "The FDA understands the importance of this type of innovation and the need to regulate it appropriately, and we could not be more pleased with the speed at which they reviewed and approved this important innovation."